"2026 has a real potential to turn the tables on obesity, haddies, pills, and wider coverage. Obesity drugs could shift from niche to mainstream in 2026 as oral GLP-1 pills and broader government coverage reshape demand."
https://www.tradingview.com/news/DJN_DN20251219007002:0/
Let´s go, Pommesbude 🤓
